Art

J-GLOBAL ID：202302214310831873   Reference number：23A1566123

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond

腫瘍免疫療法における骨髄由来サプレッサー細胞の標的化:現在,未来,そして将来【JST・京大機械翻訳】

Author (4)： Zhao Yang (1State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China) ,  Zhao Yang (2Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China) ,  Du Junfeng (3Department of General Surgery, The 7th Medical Center, Chinese People’s Liberation Army General Hospital, Beijing, China) ,  Shen Xiaofei (4Department of General Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China)
Material： Frontiers in Immunology (Web)
Volume： 14  Page： 1157537  Publication year： 2023 
JST Material Number： U7074A  ISSN： 1664-3224  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Myeloid-derived suppressor cel...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=23A1566123&from=J-GLOBAL&jstjournalNo=U7074A") }}

Thesaurus term： *bone marrow ,  *tumor ,  differentiation(biology) ,  immunosuppression ,  T cell ,  macrophage ,  dendritic cell ,  NK cell ,  *targeting ,  tumor process ,  neoplasm staging ,  regulatory T cell
Semi thesaurus term： 腫瘍進行 ,  *癌免疫療法 ,  免疫回避 ,  腫瘍関連マクロファージ ,  腫瘍発生部位 ,  *MDSC , 【Automatic Indexing@JST】

Author keywords (5)： myeloid-derived suppressor cells ,  tumor immunotherapy ,  tumor immune microenvironment ,  combinatorial strategies ,  cell therapy

JST classification (2)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Tumor immunity  (ED03040A)

Reference (182)：

• Brown JM. Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther (2002) 1(5):453-8. doi: doi: 10.4161/cbt.1.5.157
• Li L, Yu R, Cai T, Chen Z, Lan M, Zou T, et al. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment. Int Immunopharmacol (2020) 88:106939. doi: doi: 10.1016/j.intimp.2020.106939
• Dysthe M, Parihar R. Myeloid-derived suppressor cells in the tumor microenvironment. Adv Exp Med Biol (2020) 1224:117-40. doi: doi: 10.1007/978-3-030-35723-8_8
• Wu K, Lin K, Li X, Yuan X, Xu P, Ni P, et al. Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment. Front Immunol (2020) 11:1731. doi: doi: 10.3389/fimmu.2020.01731
• Li C, Jiang P, Wei S, Xu X, Wang J. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol Cancer (2020) 19(1):116. doi: doi: 10.1158/1557-3125.HIPPO19-B11

Terms in the title (4)： 腫瘍免疫療法 ,  骨髄由来サプレッサー細胞 ,  標的化 ,  未来